This is an initiative of EUROPADnet
Dear Colleague!
There is currently no evidence to guide decisions when splenectomy is being considered in patients with common variable immunodeficiency.
Unravelling Human Immune Physiology
November 28th to December 4th , 2010
ESID Clinical Working Party
More informationWe are actively encouraging our colleagues around the world to participate in the "BCG infection in SCID patients interest group" by submitting and sharing their experience.
More informationThe next combined ESID/IPOPI/INGID Meeting will take place from October 6-9 2010 in Istanbul.
Florence has just been elected to host the congress in 2012. Congratulations to Florence!
|
 |
 |
 |
To register for the ESID platform and to become an ESID Member please click here.
To activate or to renew your ESID membership by paying the membership fee please click here.
The European Society for Immunodeficiencies (ESID) is a non-profit organization having multiple aims. The main objectives are to facilitate the exchange of ideas and information among doctors, nurses, biomedical investigators, patients and their families concerned with primary immunodeficiency diseases and also to promote research on causes, mechanisms and treatment of these disorders. Recently ESID has initiated an educational program.
ESID was established as an informal group in 1983 and became a society in 1994. ESID organizes bi-annual scientific meetings, click here to get information about the next meeting.
We hope that you will find the information at our web site useful. ESID welcomes members from all over the world. It is only through a global presence that ESID will continue to be successful.
The ESID Board
Statistical graphs and information on total number of patients, diagnosis and documenting centers.
Current total number of patients
| 2010 |  | (n=12,125) |
